RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer.
about
RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
RPN2 is effective biomarker to ...... n for advanced gastric cancer.
@en
RPN2 is effective biomarker to ...... n for advanced gastric cancer.
@nl
type
label
RPN2 is effective biomarker to ...... n for advanced gastric cancer.
@en
RPN2 is effective biomarker to ...... n for advanced gastric cancer.
@nl
prefLabel
RPN2 is effective biomarker to ...... n for advanced gastric cancer.
@en
RPN2 is effective biomarker to ...... n for advanced gastric cancer.
@nl
P2093
P2860
P356
P1433
P1476
RPN2 is effective biomarker to ...... n for advanced gastric cancer.
@en
P2093
Daisuke Fujimoto
Kenji Koneri
Takanori Goi
Yasuo Hirono
P2860
P304
15208-15218
P356
10.18632/ONCOTARGET.24622
P407
P577
2018-03-08T00:00:00Z